Showing results (2251-2260 of 2,407) with videos related to

Sort By:
Pageof 241
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2016
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case studyC J Morrow, F Trapani, R L Metcalf, et al.
Reproductive Biomedicine Online|May 6, 2022
PGDIS position statement on the transfer of mosaic embryos 2021D Leigh, D S Cram, S Rechitsky, et al.
Cancer Research|April 15, 2021
Genetic Variation and Recurrent Haplotypes on Chromosome 6q23-25 Risk Locus in Familial Lung CancerAnthony M Musolf, Claire L Simpson, Bilal A Moiz, et al.
Antiviral Therapy|March 21, 2000
Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study GroupL E Chapman, G J Mertz, C J Peters, et al.
Pediatric Dermatology|February 21, 2025
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled TrialLawrence F Eichenfield, Rocco Serrao, Vimal H Prajapati, et al.
American Journal of Obstetrics and Gynecology|January 2, 2021
Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrumScott A Shainker, Beverly Coleman, Ilan E Timor-Tritsch, et al.
Obstetrics and Gynecology|June 3, 2004
Late first-trimester invasive prenatal diagnosis: results of an international randomized trialJ Philip, R K Silver, R D Wilson, et al.
Lancet (London, England)|October 12, 2015
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trialDiamant Thaçi, Eric L Simpson, Lisa A Beck, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung CancerAlessia Catozzi, Maria Peiris-Pagès, Sam Humphrey, et al.
Lancet (London, England)|May 23, 2021
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trialsEmma Guttman-Yassky, Henrique D Teixeira, Eric L Simpson, et al.
Pageof 241